What is it about?
Myopia progression in children can be monitored by measuring the depth of the eye as it elongates. Low-dose Atropine drops have been found to reduce this progression in clinical trials. In this study in the clinical setting, measuring the axial length of the eye and change over time was used to decide who to treat for progressive myopia and also to document the change once a Low dose of Atropine was initiated in a mixture of ethnicities in Australia.
Featured Image
Photo by David Travis on Unsplash
Why is it important?
Myopia progression in children is due to the growth of the eye. High myopia is defined as myopia greater than six dioptres and is associated with significant and potentially sight-threatening diseases later in life. Slowing the progression will reduce this burden of eye disease worldwide. Differentiating who may need treatment and if the treatment effect is significant enough will help provide the best management for these children.
Perspectives
I hope this provides the framework to manage children with progressive myopia best
loreto rose
Macquarie University
Read the Original
This page is a summary of: Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01%, PLoS ONE, July 2021, PLOS,
DOI: 10.1371/journal.pone.0254061.
You can read the full text:
Contributors
The following have contributed to this page
